Genmab — Maj 2016
-
Genmab A/S: First Participants Dosed in Clinical Study with DuoBody Product
Media Release -- Treatment of first study participants with DuoBody product marks clinical progress in collaboration with Janssen Copenhagen, Denmark; May 20, 2016 - Genmab A/S (Nasdaq Copenhagen:
FinanzNachrichten.de (www.finanznachrichten.de)
-
-
Det er fint at se på TA. Tænk på hvor mange som handler på den slags. Vi andre kan så følge med i slipstrømmen.
-

-
Personligt ser en amatør som jeg mest på omsætning på stigninger og fald. Det fungerer fint for mig.
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
TA i biotek er som numerologi uden evnen til at regne.